The Government recognises the need for additional investment in mental health services and the Institute for Public Policy Research report represents a valuable contribution to the debate.<\/p>
<\/p>
The Government announced its long term financial settlement for the National Health Service in June. This will represent an increase of £20.5 billion in real terms by 2023/24 and the chancellor has already announced that at least a further £2 billion of this will go to fund mental health, including expanding crisis services and supporting more people with severe mental illness into employment.<\/p>
<\/p>
The Government has asked the NHS to develop a long term plan which will set out a vision for the health service and ensure every penny is well spent. The Government has been clear that better access to mental health services, to help achieve the Government\u2019s commitment to parity of esteem between mental and physical health, is one of the principles which must underpin the plan. Further details will follow when the plan is published in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-11-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-28T14:22:14.093Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the report entitled Fair funding for mental health: Putting parity into practice, published by IPPR in October 2018, if he will make an assessment of the implications for his policies of the finding in that report that NHS mental health services require an increase in spending of at least (a) five per cent up to 2023-24 and (b) 5.5 per cent by 2030-31 to achieve parity of esteem.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4615", "label" : {"_value" : "Biography information for Lloyd Russell-Moyle"} } , "tablingMemberConstituency" : {"_value" : "Brighton, Kemptown"} , "tablingMemberPrinted" : [{"_value" : "Lloyd Russell-Moyle"} ], "uin" : "194122"} , {"_about" : "http://data.parliament.uk/resources/1011452", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011452/answer", "answerText" : {"_value" : "
Public Health England (PHE) has not made an assessment of the financial cost to society of emissions from waste incinerators. PHE\u2019s position is that well run and regulated modern municipal waste incinerators are not a significant risk to public health.<\/p>
<\/p>
Waste management facilities are regulated in England by the Environment Agency (EA) under the Environmental Permitting (England and Wales) Regulations 2010. When consulted, PHE provides an expert and independent opinion to the regulator (EA) on the potential impacts on human health of emissions arising from existing or proposed regulated facilities. PHE will comment on the applicants\u2019 risk assessments and how they demonstrate the installation\u2019s impacts on human health, and when requested, any additional modelling and assessments conducted by the EA, providing health advice that is clear, concise and based on best available evidence and expert judgement.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-29", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "194037"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-29T14:13:49.257Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Incinerators: Health Hazards"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether Public Health England has made an assessment of the financial cost to society of emissions from waste incinerators.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/252", "label" : {"_value" : "Biography information for Dr David Drew"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Dr David Drew"} ], "uin" : "194030"} , {"_about" : "http://data.parliament.uk/resources/1011473", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011473/answer", "answerText" : {"_value" : "
No such estimate has been made. Prescription forms do not include a clinical indication, therefore it is not possible to identify prescription items dispensed to treat mental health conditions.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T17:49:38.587Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Illness: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of under-16s who have regular prescriptions for medication due to long-term mental health conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "194034"} , {"_about" : "http://data.parliament.uk/resources/1011474", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011474/answer", "answerText" : {"_value" : "
The Government and its health partners recognise that it is important to ensure that people who have survived any form of critical incident have appropriate, evidence based mental health support if needed.<\/p>
<\/p>
It is essential that the mental health response is proportionate to the situation and the specific models of service delivery are a matter for NHS England and the local National Health Service.<\/p>
<\/p>
We are aware that health systems in London and Manchester are evaluating the response of the NHS and wider economy to their recent terrorist events. We will ensure this learning is shared with the system.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T17:27:05.863Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of access to mental health services for individuals who have been involved in a terror attack.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"} } , "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"} , "tablingMemberPrinted" : [{"_value" : "Chris Ruane"} ], "uin" : "194066"} , {"_about" : "http://data.parliament.uk/resources/1011502", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011502/answer", "answerText" : {"_value" : "
In 2014, the Government introduced a new statutory framework requiring local authorities and clinical commissioning groups to commission jointly services for children with special educational needs and disability, across health, social care and education. Since 2014, £327 million has been given to local areas to support implementation of these new arrangements, in addition to the high needs budget for placements for pupils with complex special educational needs.<\/p>
<\/p>
In addition to their role inspecting providers, Ofsted and the Care Quality Commission are jointly inspecting every local area\u2019s arrangements. The inspections assess the effectiveness of joint arrangements by commissioners of health, education and social care to support children with special educational needs, with written statements of action required where improvement is needed.<\/p>
<\/p>
Improving wheelchair access for children has been included as a \u2018must do\u2019 in NHS England\u2019s planning guidance for clinical commissioning groups (CCGs) for 2017/18 \u2013 2018/19, which was issued in September 2016. Each CCG is required to set out improvement plans showing how they would halve the number of children waiting 18 weeks by Q4 2017/18 and eliminate 18 week waits for wheelchairs by the end of 2018/19.<\/p>
<\/p>
In April 2018, we announced investment of £1.5 million in child sports prostheses across 2018/19 and 2019/20 for the provision of child sports protheses and research.<\/p>
<\/p>
In 2019 we will be consulting on introducing mandatory learning disability training for health and care staff.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2018-11-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-28T14:19:55.797Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Disability: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to improve the quality of health and social care services for disabled children.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4645", "label" : {"_value" : "Biography information for Emma Hardy"} } , "tablingMemberConstituency" : {"_value" : "Kingston upon Hull West and Hessle"} , "tablingMemberPrinted" : [{"_value" : "Emma Hardy"} ], "uin" : "194150"} , {"_about" : "http://data.parliament.uk/resources/1011507", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011507/answer", "answerText" : {"_value" : "
On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks\u2019 additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the unlikely the event that the UK were to leave the EU without a deal.<\/p>
<\/p>
Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.<\/p>
<\/p>
We understand medicines for breast cancer patients are vitally important to many people in this country. However, the Department recognises that through its medicines supply contingency programme, it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department\u2019s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2018-11-28", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "194160"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-28T14:02:20.69Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Breast Cancer: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of delays in drug supply chains on access to medicines for breast cancer patients in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4525", "label" : {"_value" : "Biography information for Christina Rees"} } , "tablingMemberConstituency" : {"_value" : "Neath"} , "tablingMemberPrinted" : [{"_value" : "Christina Rees"} ], "uin" : "194155"} , {"_about" : "http://data.parliament.uk/resources/1011508", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011508/answer", "answerText" : {"_value" : "
The Department has recently reviewed the impact of changes introduced by the Amendment Regulations with a particular focus on the extent to which there are any unintended consequences for the most vulnerable. The outcomes of this review will be published in due course.<\/p>
<\/p>
The Department does not collect data on the number of women who do not access maternity care because of concerns about National Health Service charging policies.<\/p>
<\/p>
The national guidance is clear that NHS maternity treatment should always be considered as immediately necessary and provided to all patients regardless of whether or not they are entitled to receive it free of charge or there are doubts about whether they could pay if subsequently found to be chargeable under the National Health Service (Charges to Overseas Visitors) Regulations 2015, as amended.<\/p>
<\/p>
Providers of NHS care need to ensure that they take necessary and appropriate steps to recover the cost of providing treatment to those not entitled to NHS-funded care. National guidance recommends that providers of NHS care should consider employing the services of a debt recovery agency that specialises in the recovery of overseas debt except in relation to persons whom it is clear to the relevant body will be unable to pay.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2018-11-29", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "194046"} , {"_value" : "194047"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-29T13:59:45.093Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Maternity Services: Fees and Charges"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of women who do not access maternity care because of concerns about NHS charging policies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/304", "label" : {"_value" : "Biography information for Mr Roger Godsiff"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Hall Green"} , "tablingMemberPrinted" : [{"_value" : "Mr Roger Godsiff"} ], "uin" : "194039"} , {"_about" : "http://data.parliament.uk/resources/1011510", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011510/answer", "answerText" : {"_value" : "
On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks\u2019 additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.<\/p>
<\/p>
Over-the-counter \u2018General Sales List\u2019 (GSL) medicines are not included in the Department\u2019s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.<\/p>
<\/p>
The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "194158"} , {"_value" : "194159"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T16:08:43.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what advice he has issued to manufacturers of general sales list medicines on whether to stockpile medicines in preparation for the UK leaving the EU without a deal; whether he plans to update that advice before the end of 2018; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3972", "label" : {"_value" : "Biography information for Baroness Chapman of Darlington"} } , "tablingMemberConstituency" : {"_value" : "Darlington"} , "tablingMemberPrinted" : [{"_value" : "Jenny Chapman"} ], "uin" : "194157"} , {"_about" : "http://data.parliament.uk/resources/1011511", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011511/answer", "answerText" : {"_value" : "
On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks\u2019 additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.<\/p>
<\/p>
Over-the-counter \u2018General Sales List\u2019 (GSL) medicines are not included in the Department\u2019s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.<\/p>
<\/p>
The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "194157"} , {"_value" : "194159"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T16:08:44.02Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people presenting at NHS services because they are unable to purchase general sales list medicines for (a) themselves and (b) their children in the event that the UK leaves the EU without a deal; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3972", "label" : {"_value" : "Biography information for Baroness Chapman of Darlington"} } , "tablingMemberConstituency" : {"_value" : "Darlington"} , "tablingMemberPrinted" : [{"_value" : "Jenny Chapman"} ], "uin" : "194158"} , {"_about" : "http://data.parliament.uk/resources/1011512", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1011512/answer", "answerText" : {"_value" : "
On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks\u2019 additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.<\/p>
<\/p>
Over-the-counter \u2018General Sales List\u2019 (GSL) medicines are not included in the Department\u2019s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.<\/p>
<\/p>
The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2018-11-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "194157"} , {"_value" : "194158"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-26T16:08:43.93Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he plans to offer financial support to manufacturers of general sales list medicines for the stockpiling of medicines in preparation for the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3972", "label" : {"_value" : "Biography information for Baroness Chapman of Darlington"} } , "tablingMemberConstituency" : {"_value" : "Darlington"} , "tablingMemberPrinted" : [{"_value" : "Jenny Chapman"} ], "uin" : "194159"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-11-21&_page=1&answeringDeptSortName=Health+and+Social+Care&max-questionFirstAnswered.=2018-11-29T14%3A13%3A49.257Z", "page" : 0, "startIndex" : 1, "totalResults" : 35, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }